Similar presentations:
Mycobacterium
1.
2.
Mycobacterium3.
Important Human PathogensMycobacterium tuberculosis
Mycobacterium leprae (uncommon)
Mycobacterium avium-intracellulaire Complex
(MAC) or (M. avium)
4.
Lipid-Rich Cell Wall of MycobacteriumMycolic acids
CMN Group:
Unusual cell wall
lipids (mycolic
acids,etc.)
(Purified Protein Derivative)
5.
Acid-Fast (Kinyoun) Stain ofMycobacterium
NOTE: cord growth (serpentine
arrangement) of virulent strains
6.
Photochromogenic Mycobacteriumkansasii on Middlebrook Agar
NOTE: Mycobacteria pathogenic
for humans can be differentiated
(Runyon Groups) by:
speed of growth (all are
slower than most other
pathogens) and by
production of chromogenic
pigments (in light, in dark,
or none)
7.
Improved Mycobacterial Isolation Medium8.
Eight Week Growth ofMycobacterium tuberculosis on
Lowenstein-Jensen Agar
9.
Pathogenic Mycobacterium spp.BCG
AIDS
patients
10.
Mycobacterial Clinical Syndromes11.
Diagramof a
Granuloma
NOTE: ultimately a
fibrin layer develops
around granuloma
(fibrosis), further
“walling off” the
lesion.
Typical progression
in pulmonary TB
involves caseation,
calcification and
cavity formation.
12.
Laboratory Diagnosis ofMycobacterial Disease
Nucleic acid probes
Nucleic acid sequencing
13.
Differential Characteristics ofCommonly Isolated
Mycobacterium spp.
14.
15.
Mycobacteriumtuberculosis
16.
Mycobacteriumtuberculosis
Infections
17.
Incidence of Tuberculosis in USA18.
Mycobacteriumtuberculosis
Infections (cont.)
Positive PPD + Chest X-Ray +
MDR-TB a serious
global health threat
BCG (bacille Calmette-Guerin)
= attenuated M. bovis
19.
Typical Progression ofPulmonary Tuberculosis
Pneumonia
Granuloma formation with fibrosis
Caseous necrosis
• Tissue becomes dry & amorphous (resembling cheese)
• Mixture of protein & fat (assimilated very slowly)
Calcification
• Ca++ salts deposited
Cavity formation
• Center liquefies & empties into bronchi
20.
PPD Tuberculosis Skin Test CriteriaPPD = Purified Protein Derivative from M. tuberculosis
21.
Chest X-Ray of Patient with ActivePulmonary Tuberculosis
22.
Mycobacterium TuberculosisStained with Fluorescent Dye
23.
24.
Mycobacterium leprae25.
Mycobacterium leprae Infections26.
Mycobacterium leprae Infections (cont.)27.
Tuberculoid vs. Lepromatous LeprosyClinical Manifestations and Immunogenicity
28.
Lepromatous vs. Tuberculoid Leprosy29.
Lepromatous Leprosy (Early/Late Stages)30.
Lepromatous Leprosy Preand Post-Treatment31.
Clinical Progression of Leprosy32.
Effect of Cell-Mediated Immunity onLeprosy Clinical Outcome
33.
34.
Mycobacterium aviumintracellulaire Complex(MAC)
35.
Mycobacterium avium-intracellulaire Infections36.
Mycobacterium avium-intracellulaire Infections37.
M. aviumintracellulaireComplex (MAC)
Progression vs.
CD4 Count in
AIDS Patients
38.
Mycobacterium avium-intracellulaire inTissue Specimens
Low Magnification
High Magnification
39.
40.
REVIEWof
Mycobacterium
41.
Important Human PathogensMycobacterium tuberculosis
Mycobacterium leprae (uncommon)
Mycobacterium avium-intracellulaire Complex
(MAC) or (M. avium)
REVIEW
42.
Lipid-Rich Cell Wall of MycobacteriumMycolic acids
CMN Group:
Unusual cell wall
lipids (mycolic
acids,etc.)
(Purified Protein Derivative)
REVIEW
43.
Pathogenic Mycobacterium spp.BCG
AIDS
patients
REVIEW
44.
Mycobacterial Clinical SyndromesREVIEW
45.
Diagramof a
Granuloma
NOTE: ultimately a
fibrin layer develops
around granuloma
(fibrosis), further
“walling off” the
lesion.
REVIEW
Typical progression
in pulmonary TB
involves caseation,
calcification and
cavity formation.
46.
Review ofMycobacterium
tuberculosis
47.
Mycobacteriumtuberculosis
Infections
REVIEW
48.
Mycobacteriumtuberculosis
Infections (cont.)
Positive PPD + Chest X-Ray +
MDR-TB a serious
global health threat
BCG (bacille Calmette-Guerin)
= attenuated M. bovis
REVIEW
49.
Typical Progression ofPulmonary Tuberculosis
Pneumonia
Granuloma formation with fibrosis
Caseous necrosis
• Tissue becomes dry & amorphous (resembling cheese)
• Mixture of protein & fat (assimilated very slowly)
Calcification
• Ca++ salts deposited
Cavity formation
• Center liquefies & empties into bronchi
REVIEW
50.
Review ofMycobacterium leprae
51.
Mycobacterium leprae InfectionsREVIEW
52.
Mycobacterium leprae Infections (cont.)REVIEW
53.
Lepromatous vs. Tuberculoid LeprosyREVIEW
54.
Lepromatous Leprosy (Early/Late Stages)REVIEW
55.
Clinical Progression of LeprosyREVIEW
56.
Effect of Cell-Mediated Immunity onLeprosy Clinical Outcome
REVIEW
57.
Review ofMycobacterium aviumintracellulaire Complex
(M. avium)
58.
Mycobacterium avium-intracellulaire InfectionsREVIEW
59.
Mycobacterium avium-intracellulaire InfectionsREVIEW
60.
M. aviumintracellulaireComplex (MAC)
Progression vs.
CD4 Count in
AIDS Patients
REVIEW